News|Articles|May 4, 2024

Top 5 Infectious Disease News Stories Week of April 27 through May 3

Author(s)Sophia Abene

This week, April FDA roundup, ESCMID conference coverage, enhancing C difficile treatment, and more from Contagion.


Related to this article

Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
FAQ: Congenital Measles
Congenital measles is a serious infection that can occur when a pregnant woman contracts measles near delivery and transmits the virus across the placenta to her newborn. Here is more information around this rare form of the disease.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.